Literature DB >> 13497364

Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).

H A ABRAMSON, B SKLAROFSKY, M O BARON, N FREMONT-SMITH.   

Abstract

Entities:  

Keywords:  LYSERGIC ACID DIETHYLAMIDE/related compounds

Mesh：

Substances：

Year:  1958        PMID： 13497364

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN： 0096-6886


× No keyword cloud information.
  5 in total

1.  A NEUROPHARMACOLOGICAL INVESTIGATION ON HALLUCINOGENIC DRUGS. LABORATORY RESULTS VERSUS CLINICAL TRIALS.

Authors:  V G LONGO; D BOVET
Journal:  Acta Neurochir (Wien)       Date:  1964       Impact factor: 2.216

2.  Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

Authors:  J P Green; C L Johnson; H Weinstein; S Maayani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 3.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  [Determination and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in the urine of acute schizophrenics (author's transl)].

Authors:  G Braun; D A Kalbhen; J Müller; H Vahar-Matiar
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-03-04

Review 5.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.